APA

Malm-Erjefält M., Bjørnsdottir I., Vanggaard J., Helleberg H., Larsen U., Oosterhuis B., van Lier J. J., Zdravkovic M. & Olsen A. K. (20110310). Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Malm-Erjefält Monika, Bjørnsdottir Inga, Vanggaard Jan, Helleberg Hans, Larsen Uffe, Oosterhuis Berend, van Lier Jan Jaap, Zdravkovic Milan and Olsen Anette K. 20110310. Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Malm-Erjefält M., Bjørnsdottir I., Vanggaard J., Helleberg H., Larsen U., Oosterhuis B., van Lier J. J., Zdravkovic M. and Olsen A. K. (20110310). Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Malm-Erjefält Monika, Bjørnsdottir Inga, Vanggaard Jan, Helleberg Hans, Larsen Uffe, Oosterhuis Berend, van Lier Jan Jaap, Zdravkovic Milan and Olsen Anette K. Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase. : Drug metabolism and disposition: the biological fate of chemicals. 20110310.